HRSA has scheduled the following webinar:
Day and Date: Thursday, June 23, 2022
Time: 2 – 3 p.m. ET
Attendees without computer access or computer audio can use the dial-in information below.
Call-In Number: 1-833-568-8864
Participant Code: 160 096 3647
HRSA will record the webinar. For a recording of the webinar, please email email@example.com
- Educational Institution
- General Public
- Local Government
- Native/Tribal Entity
- State Government
- Health and Safety
Reserved for Energy
The Rural Communities Opioid Response Program (RCORP) is a multi-year HRSA initiative aimed at reducing the morbidity and mortality of substance use disorder (SUD), including opioid use disorder (OUD), in rural communities. RCORP-MAT Access will advance RCORP’s overall goal by improving access to and quality of MAT and supportive services in rural communities. The purpose of this program is to improve health care in rural areas by establishing new MAT access points and increasing the capacity for sustainable MAT service provision in rural areas. This program is intended to support MAT to treat OUD, however HRSA encourages award recipients to also target alcohol use disorder (AUD) with MAT if the need exists.
Over the course of the three-year period of performance, RCORP-MAT Access recipients will implement activities that are aligned with the following overarching program goals:
Goal 1 – Establish new MAT access points to provide both medications and supportive services to individuals with OUD and/or AUD in rural communities;
Goal 2 – Enhance the MAT workforce through recruitment, training, and the development of peer mentorship networks;
Goal 3 – Build community capacity and infrastructure to support more effective and efficient MAT service provision; and,
Goal 4 – Ensure sustainability of the new MAT access points through improved billing and coding, as well as enrollment of eligible individuals into health insurance.
For the purposes of this NOFO, “MAT access” includes affordability, accessibility, acceptability, and availability of MAT treatment and supportive services for rural individuals who reside in the rural areas as defined by the Rural Health Grants Eligibility Analyzer. Additionally, HRSA defines MAT as the use of U.S. Food and Drug Administration (FDA)-approved medications, in combination with counseling and behavioral therapies, to provide a “whole-person” approach to the treatment of substance use disorders, including opioid use disorder and alcohol use disorder (AUD).
Related ResourcesAdditional information is available on the Resources page.
Total Amount Available:
Limit per Applicant: